The Central Power Research Institute (CPRI) has signed an MoU with the Chhattisgarh govt for setting up a regional testing laboratory in the Raipur district.
Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.